Jury Finds Chinese Vitamin C Makers Fixed Prices

Law360, New York (March 14, 2013, 4:49 PM EDT) -- A New York federal jury returned a $54.1 million verdict Thursday against North China Pharmaceutical Group Corp. and its vitamin C manufacturing unit for illegal collusion, rejecting their defense that the Chinese government forced them to fix prices and limit supply to a class of U.S. businesses.

The jury found that NCPG and its HeBei Welcome Pharmaceutical Co. Ltd. met with competitors between December 2001 and June 2006 to coordinate pricing in China's vitamin C industry. U.S. District Judge Brian Cogan said he would sign an...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.